Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 179-189

  Wang, Chong Jong ^a   Huang, Eng Yen ^a   Sun, Li Min ^a   Chen, Hui Chun ^a   Fang, Fu Min ^a   Hsu, Hsuan Chih ^a   Changchien, Chan Chao ^a   Leung, Stephen Wan ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

Author keywords

Brachytherapy; Cervical carcinoma; Fractionation scheme; High dose rate; Linear quadratic model

Indexed keywords

MEDICAL IMAGING; PATIENT MONITORING; PATIENT TREATMENT; RADIOTHERAPY; TISSUE; TUMORS;

BRACHYTHERAPY; ISOEFFECT DOSE; PATIENT OUTCOMES; TUMOR CONTROL;

ONCOLOGY;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CALCULATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTITIS; FEMALE; FOLLOW UP; FRACTIONATION; HUMAN; INCIDENCE; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MODEL; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RADIATION INJURY; TISSUE REACTION; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RECTUM; RECURRENCE; STATISTICS; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 4744353455     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.025     Document Type: Article

References (33)

1. Petereit D.G., Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 43:1999;359-366.
2. Le Pechoux C., Akine Y., Sumi M., et al. High dose rate brachytherapy for carcinoma of the uterine cervix Comparison of two different fractionation regimens. Int J Radiat Oncol Biol Phys. 31:1995;735-741.
3. Wong F.C.S., Tung S.Y., Leung T.-W., et al. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens. Int J Radiat Oncol Biol Phys. 55:2003;1254-1264.
4. Ling C.C., Sahoo N., Leibel S., et al. High dose rate gynecological applications Radiobiological considerations based on the α/β model. Radiother Oncol. 25:1992;103-110.
5. Brenner D.J., Hall E.J. Fractionated high dose rate vs. low dose rate regimens for intracavitary brachytherapy of the cervix. Br J Radiol. 64:1991;133-141.
6. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
7. Dale R.G. The use of small fraction numbers in high dose rate gynecological afterloading Some radiobiological considerations. Br J Radiol. 63:1990;290-294.
8. Sood B., Garg M., Avadhani J., et al. Predictive value of linear-quadratic model in the treatment of cervical cancer using high dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 54:2002;1377-1387.
9. Orton C.G. High dose rate vs. low dose rate brachytherapy for gynecological cancer. Semin Radiat Oncol. 3:1993;232-239.
10. Wang C.-J., Leung S.W., Chen H.-C., et al. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma 5-year results and implication of increased low-grade rectal complication on initiation an HDR-IC fractionation scheme. Int J Radiat Oncol Biol Phys. 38:1997;391-398.
11. Chen M.-S., Lin F.-J., Hong C.-H., et al. High-dose-rate afterloading technique in the radiation treatment of uterine cervical cancer 399 cases and 9 years experience in Taiwan. Int J Radiat Oncol Biol Phys. 20:1991;915-919.
12. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
13. Takeshi K., Katsuyuki K., Yoshiaki T., et al. Definitive radiotherapy combined with high dose rate brachytherapy for Stage III carcinoma of the uterine cervix Retrospective analysis of prognostic factors concerning patients characteristics and treatment parameters. Int J Radiat Oncol Biol Phys. 41:1998;319-327.
14. Petereit D.G., Sarkaria J.N., Potter D.M., et al. High-dose-rate vs. low-dose-rate brachytherapy in the treatment of cervical cancer Analysis of tumor recurrence - The University of Wisconsin experience. Int J Radiat Oncol Biol Phys. 45:1999;1267-1274.
15. Barillot I., Horiot J.C., Maingo P., et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinoma Baseline results to compare new strategies. Int J Radiat Oncol Biol Phys. 48:2000;189-200.
16. Huang E.Y., Lin H., Hsu H.C., et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol. 79:2000;406-410.
17. Ferrigno R., Novaes P.E.R.D.S., Pellizzon A.C.A., et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer Analysis of dose effectiveness and late complication. Int J Radiat Oncol Biol Phys. 50:2001;1123-1135.
18. Fyles A., Keane T.J., Barton M., et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 25:1992;273-279.
19. Petereit D.G., Sakaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1301-1307.
20. Lanciano R.M., Pajak T.F., Martz K., et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix. Cancer. 69:1992;2124-2130.
21. Girinsky T., Rey A., Roche B., et al. Overall treatment time in advanced cervical carcinoma A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys. 27:1993;1051-1056.
22. Perez C.A., Grigsby P.W., Castro-Vita H., et al. Carcinoma of the uterine cervix Impact of prolongation of treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 32:1995;1275-1288.
23. Chen S.W., Liang J.A., Yang S.N., et al. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol. 67:2003;69-76.
24. Nag S., Erickson B., Thomadsen B., et al. The American Brachytherapy Society recommendations for high dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 48:2000;201-211.
25. Coia L., Won M., Lanciano R., et al. The patterns of care outcome study for cancer of the uterine cervix Results of the second National Practice Survey. Cancer. 9:1990;431-436.
26. Fyles A.W., Pintilie M., Kirkbridge P., et al. Prognostic factors in patients with cervix cancer treated by radiation therapy Results of a multiple regression analysis. Radiother Oncol. 35:1995;107-117.
27. Ferrigno R., Oliveira Faria S.L.C., Weltman E., et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low dose rate brachytherapy Retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys. 55:2003;695-706.
28. Barillot I., Horiot J.C., Pigneaux J., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone A French cooperative study - Update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys. 38:1997;969-978.
29. Sood B.M., Gorla G., Gupta S., et al. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer Clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys. 53:2002;702-706.
30. Dubray B.M., Thames H.D. Chronic radiation damage in the rate rectum An analysis of the influences of fractionation, time, and volume. Radiother Oncol. 33:1994;41-47.
31. Morris M., Eifel P., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.
32. Rose P.G., Bundy N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
33. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix A systematic review and meta-analysis. Lancet. 358:2001;781-786.